Loading stock analysis…
Evidence Synthesis
Last synthesized: 9 Jul 2026, 11:48
Evidence Synthesis
MAXHEALTH's 62.42% is accelerating, up from 22.56% (quarterly cadence).
This represents a 0.354 magnitude increase. The company's .56% is also accelerating, up from .23% (quarterly cadence). Additionally, MAXHEALTH's .2% is accelerating, up from .3% (quarterly cadence). The .8 INR is decelerating, down from .4 INR (daily cadence).
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 62.42 % | 22.56 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 22.56 % | 17.23 | ▲ |
| REVENUE_GROWTH_YOY | 12.2 % | 7.3 | ▲ |
| EPS_ACTUAL | 3.15 INR | 5.02 | ▼ |
| EPS_SURPRISE_PERCENT | -0.19 % | 0.21 | ▼ |
| PRICE_CHANGE_PERCENT | -3.004 % | — | - |
| DAILY_VOLUME | 19,70,743 shares | 26,73,444 | ▼ |
| CLOSE_PRICE | 1,084.8 INR | 1,118.4 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.59 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 8 count | 12 | ▼ |
| TARGET_PRICE_PREMIUM | 6.84 % | — | - |